The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Patient's Perception of Symptoms Related to Morning Activity in Chronic Obstructive Pulmonary Disease: The SYMBOL Study

  • Kim, Yeon Jae (Division of Pulmonary and Critical Care Medicine, Daegu Fatima Hospital) ;
  • Lee, Byung Ki (Division of Pulmonary and Critical Care Medicine, Daegu Fatima Hospital) ;
  • Jung, Chi Young (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Jeon, Young June (Department of Internal Medicine, Keimyung University School of Medicine) ;
  • Hyun, Dae Sung (Department of Internal Medicine, Catholic University of Daegu School of Medicine) ;
  • Kim, Kyung Chan (Department of Internal Medicine, Catholic University of Daegu School of Medicine) ;
  • Yu, Sung Ken (Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Choi, Hye Sook (Department of Internal Medicine, Dongguk University College of Medicine) ;
  • Shin, Won Hyuk (Department of Internal Medicine, Sunlin Hospital, Handong Global University) ;
  • Lee, Kwan Ho (Department of Internal Medicine, Yeungnam University College of Medicine)
  • Published : 2012.12.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Patients with chronic obstructive pulmonary disease (COPD) experience more problematic respiratory symptoms and have more trouble performing daily activities in the morning. The aim of this study was to assess the perception of COPD symptoms related to morning activities in patients with severe airflow limitation. Methods: Data of 133 patients with severe airflow limitation were analyzed in a prospective, non-interventional study. A clinical symptom questionnaire was completed by patients at baseline. In patients having morning symptoms, defined by at least one or more prominent or aggravating symptom during morning activities, a morning activity questionnaire was also completed at baseline and following 2 months of COPD treatment. Results: The most frequently reported COPD symptom was breathlessness (90.8%). Morning symptoms were reported in 76 (57%) patients; these had more frequent and severe clinical COPD symptoms. The most frequently reported morning activity was getting out of bed (82.9%). The long acting muscarinic antagonist (odds ratio [OR], 6.971; 95% confidence interval [CI], 1.317 to 11.905) and chest tightness (OR, 0.075; 95% CI, 0.011 to 0.518) were identified as significantly related to absence of morning symptoms. There was no significant correlation between the degree of forced expiratory volume in 1 second improvement and severity score differences of all items of morning activity after 2-month treatment. Conclusions: Fifty-seven percent of COPD patients with severe airflow limitation have morning symptoms that limit their morning activities. These patients also have more prevalent and severe COPD symptoms. The results of this study therefore provide valuable information for the development of patient-reported outcomes in COPD.

Keywords

References

  1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. 2011 rev. Global Initiative for Chronic Obstructive Lung Disease, c2011 [cited 2012 Mar 25]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf.
  2. Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009;103:757-765. https://doi.org/10.1016/j.rmed.2008.11.011
  3. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19. https://doi.org/10.1159/000050456
  4. Kim DS, Kim YS, Jung KS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-847. https://doi.org/10.1164/rccm.200502-259OC
  5. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2000;118:1278-1285. https://doi.org/10.1378/chest.118.5.1278
  6. Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomia en la EPOC: pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449-1455. https://doi.org/10.1378/chest.121.5.1449
  7. Masa JF, Sobradillo V, Villasante C, et al. Costs of chronic obstructive pulmonary disease in Spain: estimation from a population-based study. Arch Bronconeumol 2004;40:72-79.
  8. Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP. Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004;98:932-937. https://doi.org/10.1016/j.rmed.2004.03.018
  9. Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 2005;118:1415.
  10. Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J 2005;26:623-629. https://doi.org/10.1183/09031936.05.00142704
  11. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805. https://doi.org/10.1183/09031936.02.03242002
  12. Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Patient's perception of exacerbations of COPD: the PERCEIVE study. Respir Med 2007;101:453-460. https://doi.org/10.1016/j.rmed.2006.07.010
  13. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009;25:2043-2048. https://doi.org/10.1185/03007990903103006
  14. Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 2011;37:264-272. https://doi.org/10.1183/09031936.00051110
  15. Postma DS, Koeter GH, vd Mark TW, Reig RP, Sluiter HJ. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 1985;87:653-657. https://doi.org/10.1378/chest.87.5.653
  16. Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003;58:855-860. https://doi.org/10.1136/thorax.58.10.855
  17. van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006;129:509-517. https://doi.org/10.1378/chest.129.3.509
  18. McCarley C, Hanneman SK, Padhye N, Smolensky MH. A pilot home study of temporal variations of symptoms in chronic obstructive lung disease. Biol Res Nurs 2007;9:8-20. https://doi.org/10.1177/1099800407303501
  19. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136. https://doi.org/10.1164/ajrccm.152.3.7663792
  20. Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 1976;125:110-118.
  21. Sensormedics. Pulmonary Utilities Operator's Manual: Predicted Normal Equations. Yorba Linda, CA: Sensormedics Co., 1988.
  22. Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD: a review. Respir Med 2011;105:1422-1433. https://doi.org/10.1016/j.rmed.2011.05.014
  23. Monteleone P, Maj M. The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol 2008;18:701-711. https://doi.org/10.1016/j.euroneuro.2008.06.007
  24. Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995;151:61-65. https://doi.org/10.1164/ajrccm.151.1.7812573
  25. Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Ther Adv Respir Dis 2009;3:1-11.
  26. Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:741-750. https://doi.org/10.1164/rccm.200904-0492OC
  27. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-940. https://doi.org/10.1164/ajrccm/146.4.935
  28. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-1079. https://doi.org/10.7326/0003-4819-127-12-199712150-00003
  29. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency 7: Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994;49:162-170. https://doi.org/10.1136/thx.49.2.162
  30. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007;101:146-153. https://doi.org/10.1016/j.rmed.2006.04.001
  31. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-469. https://doi.org/10.1183/09031936.00099306
  32. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185. https://doi.org/10.1183/09031936.00128008
  33. Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010;80:112-119. https://doi.org/10.1159/000281880
  34. van den Bemt L, Schermer T, Smeele I, et al. Monitoring of patients with COPD: a review of current guidelines' recommendations. Respir Med 2008;102:633-641. https://doi.org/10.1016/j.rmed.2007.12.014
  35. Benzo RP, Chang CC, Farrell MH, et al. Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration 2010;80:10-18. https://doi.org/10.1159/000296504
  36. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J 2009;34:648-654. https://doi.org/10.1183/09031936.00102509
  37. Partridge MR, Miravitlles M, Stahl E, Karlsson N, Svensson K, Welte T. Development and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPD. Eur Respir J 2010;36:96-104. https://doi.org/10.1183/09031936.00123709

Cited by

  1. COPD symptoms in the morning: impact, evaluation and management vol.14, pp.1, 2012, https://doi.org/10.1186/1465-9921-14-112
  2. Symptom variability in COPD: a narrative review vol.8, pp.None, 2012, https://doi.org/10.2147/copd.s42866
  3. Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey vol.30, pp.2, 2012, https://doi.org/10.3904/kjim.2015.30.2.191
  4. Improvements in patient-reported outcomes: a prospective, non-interventional study with aclidinium bromide for treatment of COPD vol.109, pp.5, 2012, https://doi.org/10.1016/j.rmed.2015.02.004
  5. Informal caregivers of patients with COPD: Home Sweet Home? vol.24, pp.137, 2012, https://doi.org/10.1183/16000617.00010114
  6. A ferret model of COPD-related chronic bronchitis vol.1, pp.15, 2016, https://doi.org/10.1172/jci.insight.87536
  7. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG vol.26, pp.1, 2012, https://doi.org/10.1038/npjpcrm.2016.40
  8. Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD) vol.14, pp.None, 2012, https://doi.org/10.1186/s12955-016-0506-7
  9. Understanding the impact of symptoms on the burden of COPD vol.18, pp.None, 2017, https://doi.org/10.1186/s12931-017-0548-3
  10. The association between objectively measured physical activity and morning symptoms in COPD vol.12, pp.None, 2012, https://doi.org/10.2147/copd.s143387
  11. Association between morning symptoms and physical activity in COPD: a systematic review vol.26, pp.143, 2012, https://doi.org/10.1183/16000617.0033-2016
  12. Morning symptoms in COPD: a treatable yet often overlooked factor vol.11, pp.4, 2012, https://doi.org/10.1080/17476348.2017.1305894
  13. Daily Symptom Variability in Patients With Stable COPD: A Narrative Review vol.40, pp.10, 2012, https://doi.org/10.1177/0193945917705132
  14. Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms vol.19, pp.None, 2018, https://doi.org/10.1186/s12931-018-0749-4
  15. New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease vol.91, pp.3, 2012, https://doi.org/10.26442/00403660.2019.03.000136
  16. Symptom variability over the course of the day in patients with stable COPD in Brazil: a real-world observational study vol.46, pp.3, 2012, https://doi.org/10.36416/1806-3756/e20190223
  17. Daytime symptoms of chronic obstructive pulmonary disease: a systematic review vol.30, pp.1, 2012, https://doi.org/10.1038/s41533-020-0163-5